
Svetlana M. Ivanova
Examiner (ID: 240, Phone: (571)270-3277 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627 |
| Total Applications | 1080 |
| Issued Applications | 518 |
| Pending Applications | 82 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15342371
[patent_doc_number] => 20200009077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/502189
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502189 | COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES | Jul 2, 2019 | Abandoned |
Array
(
[id] => 15342373
[patent_doc_number] => 20200009078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => ORAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/502244
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502244 | ORAL COMPOSITIONS | Jul 2, 2019 | Abandoned |
Array
(
[id] => 17805705
[patent_doc_number] => 20220257540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/622152
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622152 | COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION | Jun 27, 2019 | Abandoned |
Array
(
[id] => 16197386
[patent_doc_number] => 10722522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Dosing regimen for sedation with CNS 7056 (remimazolam)
[patent_app_type] => utility
[patent_app_number] => 16/457387
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15370
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457387 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Jun 27, 2019 | Issued |
Array
(
[id] => 15320841
[patent_doc_number] => 20200000750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => Composition for Treating Acute and Chronic Pain
[patent_app_type] => utility
[patent_app_number] => 16/449676
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449676
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449676 | Composition for Treating Acute and Chronic Pain | Jun 23, 2019 | Abandoned |
Array
(
[id] => 17148367
[patent_doc_number] => 11141418
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-10-12
[patent_title] => Methods and compositions for KRAS inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/449785
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 33531
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449785 | Methods and compositions for KRAS inhibitors | Jun 23, 2019 | Issued |
Array
(
[id] => 16741992
[patent_doc_number] => 10966959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Use of a rotifer-derived compound and its analogs for preventing schistosomiasis
[patent_app_type] => utility
[patent_app_number] => 16/445766
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 8239
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445766 | Use of a rotifer-derived compound and its analogs for preventing schistosomiasis | Jun 18, 2019 | Issued |
Array
(
[id] => 17220675
[patent_doc_number] => 11173158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same
[patent_app_type] => utility
[patent_app_number] => 16/444396
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 11281
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444396
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/444396 | Medicinal agent and beverage/food for preventing cerebral dysfunction and improving same | Jun 17, 2019 | Issued |
Array
(
[id] => 17035036
[patent_doc_number] => 20210251994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => INCREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
[patent_app_type] => utility
[patent_app_number] => 17/252225
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252225 | INCREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS | Jun 13, 2019 | Abandoned |
Array
(
[id] => 14893747
[patent_doc_number] => 20190290639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/438956
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438956 | COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS | Jun 11, 2019 | Abandoned |
Array
(
[id] => 15553213
[patent_doc_number] => 20200061018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/439164
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439164 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | Jun 11, 2019 | Abandoned |
Array
(
[id] => 19624059
[patent_doc_number] => 12162863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Modulators of stimulator of interferon genes (STING)
[patent_app_type] => utility
[patent_app_number] => 17/251291
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53596
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251291 | Modulators of stimulator of interferon genes (STING) | Jun 11, 2019 | Issued |
Array
(
[id] => 15052271
[patent_doc_number] => 10456411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
[patent_app_type] => utility
[patent_app_number] => 16/437773
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6881
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16437773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/437773 | Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor | Jun 10, 2019 | Issued |
Array
(
[id] => 14926121
[patent_doc_number] => 20190298698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/433097
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433097 | Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function | Jun 5, 2019 | Issued |
Array
(
[id] => 19256802
[patent_doc_number] => 12016831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Polidocanol for use as immunomodulating agent
[patent_app_type] => utility
[patent_app_number] => 15/734825
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5752
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734825 | Polidocanol for use as immunomodulating agent | Jun 4, 2019 | Issued |
Array
(
[id] => 16960822
[patent_doc_number] => 20210212321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => STABILIZED FUNGICIDAL COMPOSITION COMPRISING CYCLODEXTRIN
[patent_app_type] => utility
[patent_app_number] => 15/734111
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734111 | STABILIZED FUNGICIDAL COMPOSITION COMPRISING CYCLODEXTRIN | May 29, 2019 | Abandoned |
Array
(
[id] => 16945849
[patent_doc_number] => 20210204540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => METHOD OF CONTROLLING POWDERY MILDEW
[patent_app_type] => utility
[patent_app_number] => 17/059797
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059797 | METHOD OF CONTROLLING POWDERY MILDEW | May 28, 2019 | Abandoned |
Array
(
[id] => 14833147
[patent_doc_number] => 20190274974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Treatment of Pain Associated with Trigeminal Neuralgia
[patent_app_type] => utility
[patent_app_number] => 16/423423
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423423 | Treatment of Pain Associated with Trigeminal Neuralgia | May 27, 2019 | Pending |
Array
(
[id] => 19651250
[patent_doc_number] => 12173018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Penicillin-binding protein inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/057593
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49950
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057593 | Penicillin-binding protein inhibitors | May 22, 2019 | Issued |
Array
(
[id] => 15738327
[patent_doc_number] => 20200108051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => METHODS OF TREATING HEPATIC ENCEPHALOPATHY
[patent_app_type] => utility
[patent_app_number] => 16/414018
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414018 | Methods of treating hepatic encephalopathy | May 15, 2019 | Issued |